Dibavog 0.3mg Tablet
Marketer
Kasdap Healthcare Pvt Ltd
Salt Composition
Voglibose (0.3mg)
Overview Dibavog 0.3mg Tablet
Glycemia-M 0.3mg tablets manage type 2 diabetes by regulating postprandial hyperglycemia. Prescribed when diet and other medications prove insufficient, this medication helps control elevated blood sugar. Take Glycemia-M 0.3mg immediately before meals; dosage and frequency are determined by your physician to optimize blood glucose control. Discontinue only under medical supervision; abrupt cessation risks dangerously high blood sugar, potentially leading to severe complications such as renal impairment and vision loss. This medication complements a comprehensive treatment plan including diet, exercise, and weight management as directed by your doctor. Regular blood sugar monitoring is crucial. Common side effects include abdominal discomfort (flatulence, pain, appetite changes, constipation, diarrhea). Report persistent or bothersome side effects to your physician. While Glycemia-M 0.3mg itself doesn't cause hypoglycemia, combined use with other diabetes medications (particularly insulin or sulfonylureas) increases this risk. Treat hypoglycemic episodes with plain glucose; table sugar is ineffective. Inform your doctor of any kidney or liver issues, bowel inflammation (e.g., Crohn's disease or ulcerative colitis), or pregnancy/breastfeeding before use. Always disclose all medications to ensure safe interaction. Limit alcohol consumption to mitigate the risk of hypoglycemia.
Uses of Dibavog 0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Dibavog 0.3mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 0.3mg Dibavog tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Dibavog 0.3mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Dibavog 0.3mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the 0.3mg Dibavog tablet whole; do not chew, crush, or fracture it. Administer on an empty stomach.
How Dibavog 0.3mg Tablet works:
Glucodown 0.3mg tablets are used to manage diabetes. Their mechanism of action involves blocking the digestive enzymes that convert complex carbohydrates into readily absorbed glucose, thus moderating postprandial hyperglycemia.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Dibavog 0.3mg tablets poses a safety risk.
PregnancySAFE IF PRESCRIBED
The medication Dibavog 0.3mg Tablet is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; however, data from human studies remain scarce.
Breast feedingSAFE IF PRESCRIBED
Using Dibavog 0.3mg tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Dibavog 0.3mg tablets.
KidneyCAUTION
For individuals with severe kidney impairment, the use of Dibavog 0.3mg tablets requires careful monitoring. Dosage modification of Dibavog 0.3mg tablets might be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with severe hepatic impairment should use 0.3mg Dibavog tablets cautiously, potentially requiring dose modification. Physician consultation is advised.
What if you forget to take Dibavog 0.3mg Tablet :
Omit any missed dose of Dibavog 0.3mg Tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dibavog 0.3mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Behavioral Class | Alpha-glucosidase inhibitors |
3,018 People bought this recently